The United States will share COVID-19 vaccines from AstraZeneca with the rest of the world once it passes federal safety expectations, according to The Associated Press. Around 60 million doses of the company's vaccine are expected to be exported globally, the White House told the AP. 'Given the strong portfolio of vaccines that the U.S. already has and that have been authorized by the FDA, and given that the AstraZeneca vaccine is not authorized for use in the U.S., we do not need to use the AstraZeneca vaccine here during the next several months,' White House COVID-19 coordinator Jeff Zients told […]
The post US to export AstraZeneca COVID-19 vaccines for global use appeared first on BNC.
